Below are the best articles we could find on Psychedelic Research and psychedelic assisted therapy.
CLEAR ALL
Psychedelics can unlock a newfound appreciation of nature, a profound sense of being part of a much larger whole and of a magnificent interconnected web of life.
Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.
Could there be one factor that links together conflict, climate change, racism, anxiety and eating disorders?
1
A federal health agency hosted a leading psychedelics researcher on Tuesday for an event focused on the therapeutic potential of controlled substances such as psilocybin and DMT.
“Epigenetic changes will be measured after MDMA-assisted psychotherapy in a first of its kind study,” explains Dr. Joe Tafur about a research collaboration with MAPS investigators, the Modern Spirit research team, and the University of Southern California, Department of Psychiatry.
A new review from neuroethicist Eddie Jacobs, and published in the Journal of Psychedelic Studies, is suggesting psilocybin may have great potential as a treatment for obsessive-compulsive disorder (OCD).
Scientist Robin Carhart-Harris wants to use psychedelic drugs to treat psychiatric disorders. Early results are promising—but can he convince big pharma and the public of their potential?
People of color are dealing with racism all the time, in large and small ways, and even dealing with racism in healthcare, even dealing with racism in therapy.
The drug known by the street names Ecstasy or Molly could be a promising treatment for post-traumatic stress disorder, according to a new study.
Psilocybin, MDMA, and ketamine can lead to a new sense of self and a release from rigid rules for people with anorexia, bulimia, and binge-eating disorder.
To continue customizing your FindCenter experience, create an account. It’s free!
Create an account to discover wisdom, save your favorite content, and connect with teachers and seekers.
IT’S FREE
If you already have an account, please log in.
